• Background: The aim of the study was to demonstrate the safety and effectiveness of a suture-mediated vascular closure device to perform hemostasis after an axillary artery access during endovascular procedures on the aortic valve, the aorta and its side branches. (lu.se)
  • Conclusions: Percutaneous transaxillary aortic procedures, in selected patients, can be performed with low rates of open conversion. (lu.se)
  • Methods: All patients undergoing transfemoral transcatheter aortic valve replacement (TAVR) between January 2016 and May 2020 with MANTA closure were included. (eur.nl)
  • CONCLUSIONS: The PFO closure procedure appeared to be safe and was associated with the majority of divers being able to successfully return to unrestricted diving. (who.int)
  • Percutaneous Interventions for Congenital Heart Disease is written for pediatric cardiologists specializing in interventional cardiology and need a step-by-step guide to carrying out procedures, as well as adult cardiologists. (routledge.com)
  • He performs percutaneous coronary interventions, transcatheter valve replacement and repair, and transcatheter closure of patent foramen ovale (PFO) and atrial septal defects (ASD). (massgeneral.org)
  • Percutaneous coronary interventions (PCI) include percutaneous transluminal coronary angioplasty (PTCA) with or without stent insertion. (msdmanuals.com)
  • Aggarwal R, John R, Knoper R. Anterior Ischemic VSD Repair After Failed Percutaneous Device Closure. (ctsnet.org)
  • The video shows an anterior approach using a single patch technique for a ventricular septal rupture presumed to be from an ischemic event after a failed percutaneous device closure. (ctsnet.org)
  • The defect and closure device were well visualized, and the closure device was removed with ease. (ctsnet.org)
  • Patients undergoing LAA closure were randomly assigned (1:1) open-label to receive Amulet or Watchman 2.5 or FLX (Watchman) across 8 European centers in the investigator-initiated SWISS APERO trial (Comparison of Amulet Versus Watchman/FLX Device in Patients Undergoing Left Atrial Appendage Closure). (physiciansweekly.com)
  • At 45 days, the primary end outcome was a composite of justified crossover to a nonrandomized device during the LAA closure operation or residual LAA patency revealed by cardiac computed tomography angiography (CCTA). (physiciansweekly.com)
  • The aim of this study was to assess the efficacy and safety of the Occlutech Paravalvular Leak Device (PLD) for the percutaneous closure of paravalvular leaks (PVL). (pcronline.com)
  • Methods: A physician-initiated, international, multicenter, retrospective registry was designed to evaluate the success rate (VARC-2 reporting standards) of percutaneous transaxillary access closure with a suture-mediated closure device. (lu.se)
  • Percutaneous closure of PFO, a minimally invasive procedure to close the PFO using a device can help patients with cryptogenic stroke to reduce the risk of recurrent stroke. (heartvascularcentre.com)
  • The PFO device closure is performed in a catheterization laboratory with fluoroscopic (live X-ray) and TEE guidance. (heartvascularcentre.com)
  • Scholars@Duke publication: Percutaneous steerable robotic tool delivery platform and metal microelectromechanical systems device for tissue manipulation and approximation: closure of patent foramen ovale in an animal model. (duke.edu)
  • Percutaneous device closure of atrial septal defects (ASD) has proven to be safe and it is nowadays the standard treatment for ASDs. (openaccesspub.org)
  • Immediate or late device embolization is a rare but potential complication of every attempted ASD device closure. (openaccesspub.org)
  • With the accelerated growth in transcatheter device closure, many centres started to report outcome data for this procedure with a general interest focused on its complications. (openaccesspub.org)
  • Then, transcatheter PDA closure was performed by 6×7 mm ADO-I device. (thoracickey.com)
  • Of the closure patients, 1 (1.4%) developed thrombus (Amplatzer ASO device). (structuralheartdisease.org)
  • Rapid Normalization Following Percutaneous Secundum Atrial Septal Defect Device Closure. (wikipedia.org)
  • Percutaneous device closure was shown to effectively prevent recurrent strokes in patients with patent foramen ovale (PFO). (karger.com)
  • Background: The MANTA vascular closure device (VCD) is dedicated to large bore access closure and associated with favorable results in selected study populations. (eur.nl)
  • Conclusion: In this contemporary TAVR population, access-site related complications occurred in 8% of patients and were mainly due to percutaneous closure device failure. (eur.nl)
  • All the devices were inserted in the cardiac catheterization lab using our previously described techniques for percutaneous axillary access and performed using a combination of palpation, vascular ultrasound, and angiographic visualization [ 4 ]. (hindawi.com)
  • Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a nonsurgical technique for treating obstructive coronary artery disease, including unstable angina, acute myocardial infarction (MI), and multivessel coronary artery disease (CAD). (medscape.com)
  • Example of an intravascular ultrasound (IVUS) image in percutaneous transluminal coronary angioplasty (PTCA). (medscape.com)
  • To date, no study compared Amulet to the new Watchman FLX in terms of residual LAA patency or clinical outcomes in patients with percutaneous LAA closure. (physiciansweekly.com)
  • Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience. (ox.ac.uk)
  • Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. (wikipedia.org)
  • Initial results using these tools to perform patent foramen ovale closure are described. (duke.edu)
  • As a demonstration of both technologies, patent foramen ovale creation and closure was performed in a swine model. (duke.edu)
  • The latter is the typical reason for percutaneous patent foramen ovale (PFO) closure. (viamedica.pl)
  • The purpose of this study was to assess whether pre-existing thrombophilia predisposes patients to adverse events after percutaneous patent foramen ovale (PFO) or atrial septal defect (ASD) closure. (structuralheartdisease.org)
  • For many years, percutaneous interventional occlusion of congenital patent ductus arteriosus (PDA) has been completed using radiation and contrast agents. (biomedcentral.com)
  • Thirteen consecutive patients, older than 40 years without any clinical or electrocardio-graphic evidence of AF, underwent percutaneous closure of large ASDs or PFOs in the presence of enlarged atria at the university hospitals of Bern and Zurich between April 2013 and June 2015. (viamedica.pl)
  • Results: A total of 116 patients, the majority of which were female (58%), underwent 118 percutaneous procedures for VSD closure at a median age of 3.54 years (range: 0.25-33 years) and a median weight of 12 kg (range: 3.5-78 kg). (elsevierpure.com)
  • 69 (46.9%) underwent closure. (structuralheartdisease.org)
  • Results: The 512 patients underwent TAVR with MANTA access closure. (eur.nl)
  • Percutaneous transluminal angioplasty (PTA) Peripheral arterial disease (PAD) is atherosclerosis of the extremities (virtually always lower) causing ischemia. (msdmanuals.com)
  • Percutaneous atrial septal defect (ASD) closure is a routine procedure to prevent right ventricular failure, pulmonary hypertension, or paradoxical embolism. (viamedica.pl)
  • Percutaneous (catheter-based) closure is the procedure of choice for adults and older children with a PDA, but use during infancy (<1 year) is not well characterized. (mcmaster.ca)
  • 2 Percutaneous atrial septal defect closure using the Amplatzer septal occluder (ABBOTT) or many other devices is an established alternative treatment to the classical surgery with excellent safety, clinical outcome, being an effective procedure. (openaccesspub.org)
  • In the last 2 decades, this technique replaced surgical closure of ASDs in most centres, becoming a widely accepted and practiced procedure. (openaccesspub.org)
  • As in any interventional cardiac catheterisation procedure, percutaneous transcatheter ASD closure is associated with all the general risks, the most common and frequent immediate complications related to the transcatheter itself being vessel or cardiac perforation, the introduction of an infectious pathogen and the risk of contrast agent reactions. (openaccesspub.org)
  • The primary endpoint was LAA closure as determined by transesophageal echocardiography (TEE) two months after the procedure and stroke rate at 150 patient years. (nih.gov)
  • PDA closure guided by transthoracic echocardiography via femoral artery puncture is a minimally invasive procedure that avoids injuries due to radiation and contrast agents. (biomedcentral.com)
  • Our experienced, board-certified interventional cardiologists employ the very latest technology in two, full-service catheterization suites and a specially-equipped hybrid suite for performing percutaneous valve replacements. (providence.org)
  • This complication has been described and has been treated by either percutaneous puncture of the balloon or operative exploration. (sages.org)
  • PTCA is done via percutaneous femoral, radial, or brachial artery puncture. (msdmanuals.com)
  • Secondary closure success was obtained in 325 patients (98%) after 7 bare stenting, 37 covered stenting, and 1 thrombin injection. (lu.se)
  • Primary closure success was 90.3% in the 175 patients with sheaths smaller than 16F, performed after the first 5 procedures in each center. (lu.se)
  • Percutaneous left atrial appendage (LAA) closure is emerging as a preven-tive therapy for patients in AF who suffered from a previous stroke or bleeding (secondary prevention) or patients without previous stroke or bleeding (primary prevention). (viamedica.pl)
  • Reported herein is the feasibility and safety of concomitant percutaneous closure of the LAA and a septal shunt, mostly large ASDs, in patients without AF, in the sense of "primary primary" preventive LAA closure. (viamedica.pl)
  • Percutaneous closure is a feasible and effective choice even in patients who had no prior sternotomy or who reject surgery as a primary treatment strategy. (bvsalud.org)
  • Some thrombophilic patients have been excluded from clinical trials of septal defect closure due to the presumed higher risk of thrombus formation. (structuralheartdisease.org)
  • This study focused on this specific group of pediatric patients and explored the safety and effectiveness of percutaneous occlusion of PDA in children under transthoracic ultrasound guidance. (biomedcentral.com)
  • Percutaneous axillary vascular access has recently re-emerged as an alternative percutaneous access option for large bore arteriotomies in patients with severe or occlusive iliofemoral vascular disease and in fact has now become the most utilized alternative access technique in the United States. (hindawi.com)
  • L'objectif de notre étude était d'évaluer la qualité de sa prise en charge chez les patients adultes hospitalisés au CNHUHKM de Cotonou. (bvsalud.org)
  • En dépit de la forte prévalence et de la sévérité de la douleur, près de 2 sur 3 patients (70,1%) d'entre eux étaient au moins modérément satisfaits du traitement antalgique. (bvsalud.org)
  • The European PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study was performed to determine the safety and efficacy of left atrial appendage occlusion by catheter technique. (nih.gov)
  • In this study, transthoracic echocardiography without radiation and contrast agents was used to complete percutaneous occlusion of pediatric PDA. (biomedcentral.com)
  • Secondary endpoints included bleeding, time to hemostasis, procedural length and incomplete arteriotomy closure or arterial occlusion by angiography. (eur.nl)
  • We describe a rare cause of hemolysis complicating transcatheter closure of a post-traumatic ventricular septal defect. (elsevierpure.com)
  • Primary percutaneous closure of a traumatic ventricular septal defect after stab wound to the chest: a case report. (bvsalud.org)
  • PVL closure with the Occlutech PLD demonstrated a high success rate associated with significant clinical improvement and a relatively low rate of serious complications. (pcronline.com)
  • Transcatheter PVL closure with the specifically designed PLD was demonstrated to be effective with a relatively low rate of major complications. (pcronline.com)
  • AHA Florida 2007 The Relative Atrial Index - A Transthoracic Echocardiographic Indicator of Intracardiac Shunt Status Pre and Post Amplatzer Atrial Septal Defect Closure. (wikipedia.org)
  • A threshold of five percutaneous axillary accesses was associated with decreased rates of open conversion, but not with increased primary closure success. (lu.se)
  • The prevalence of peripheral vascular disease has led to the re-emergence of percutaneous axillary vascular access as a suitable alternative access site to femoral artery. (hindawi.com)
  • We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system. (go.jp)
  • abstract = "Objectives: This study aimed to review the experience with percutaneous closure of ventricular septal defects (VSDs) at the National Heart Center (NHC) in Muscat, Oman. (elsevierpure.com)
  • Soon after dislodgement, Foley catheters are often placed through the mature gastrocutaneous fistula to prevent tract closure until more definitive replacement occurs. (sages.org)
  • In the majority of the infants, closure of the foramen ovale occurs naturally after birth as negative intrathoracic pressure caused by the infants' first breaths will cause the PFO to close. (heartvascularcentre.com)
  • Conclusion: This study has demonstrated a good rate of VSD closure with low morbidity and no mortality using the percutaneous approach with different devices. (elsevierpure.com)
  • Percutaneous septal closure, particularly that of large ASDs, may inhibit future percutaneous left atrial access when required for LAA closure. (viamedica.pl)
  • The standard of care is surgical closure or secondary percutaneous closure due to high surgical risk because of recent sternotomy . (bvsalud.org)
  • a rate lower than a recent randomised trial of PFO closure for stroke. (who.int)
  • One patient with a previously repaired mitral valve had a stroke that was thought to be unrelated to the PFO closure. (who.int)
  • There are no randomised controlled trial data to support PFO closure for the prevention of decompression illness (DCI), so the need for audit data on the safety and ef fi cacy of this technique has been recognised by the National Institute of Health and Clinical Excellence in the UK. (who.int)
  • Concomitant closure of ASD or PFO in the presence of enlarged atria and LAA for "primary primary" prevention appears feasible and safe but has yet to prove its justification. (viamedica.pl)
  • Indications for PVL closure were heart failure and/or haemolytic anaemia. (pcronline.com)
  • Other potential indications for closure include systemic embolisation, decompression sickness, platypnoea-orthodeoxia syndrome, amaurosis fugax, and migraine with aura. (heartvascularcentre.com)
  • 69.2% males) in 11 centers received a percutaneous transaxillary access during endovascular cardiac (n = 166) or vascular (n = 165) procedures. (lu.se)
  • Procedural success for ML and AL closure was high with a low rate of residual or recurrent leaks. (pcronline.com)